425 related articles for article (PubMed ID: 26454084)
21. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
[TBL] [Abstract][Full Text] [Related]
22. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
von dem Borne PA; Meijers JC; Bouma BN
Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397
[TBL] [Abstract][Full Text] [Related]
23. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
Jen CJ; McIntire LV
Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
[TBL] [Abstract][Full Text] [Related]
24. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.
Zubairova LD; Nabiullina RM; Nagaswami C; Zuev YF; Mustafin IG; Litvinov RI; Weisel JW
Sci Rep; 2015 Dec; 5():17611. PubMed ID: 26635081
[TBL] [Abstract][Full Text] [Related]
25. The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.
Hudák R; Vincze J; Csernoch L; Beke Debreceni I; Oláh T; Erdődi F; Clemetson KJ; Kappelmayer J
Biomed Res Int; 2017; 2017():9795271. PubMed ID: 28680886
[TBL] [Abstract][Full Text] [Related]
26. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
Carr ME; Carr SL; Merten SR
Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656
[TBL] [Abstract][Full Text] [Related]
27. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
28. Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus.
Udvardy M; Posan E; Harsfalvi J
Thromb Res; 1995 Jul; 79(1):57-63. PubMed ID: 7495104
[TBL] [Abstract][Full Text] [Related]
29. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Loza JP; Gurewich V; Johnstone M; Pannell R
Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
[TBL] [Abstract][Full Text] [Related]
30. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
31. Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation.
Suehiro A; Tsujioka H; Yoshimoto H; Ueda M; Higasa S; Kakishita E
Thromb Res; 1995 Oct; 80(2):135-42. PubMed ID: 8588190
[TBL] [Abstract][Full Text] [Related]
32. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
33. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
34. [THROMBIN-MEDIATED EFFECTS OF BLOOD MICROPARTICLES ON FORMATION, STRUCTURE, AND STABILITY OF FIBRIN CLOTS].
Nabiullina RM; Mustafin IG; Ataullakhanov FI; Litvinov RI; Zubairova LD
Ross Fiziol Zh Im I M Sechenova; 2015 Jul; 101(7):812-21. PubMed ID: 26591054
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
36. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
[TBL] [Abstract][Full Text] [Related]
37. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8.
Bester J; Matshailwe C; Pretorius E
Cytokine; 2018 Oct; 110():237-242. PubMed ID: 29396046
[TBL] [Abstract][Full Text] [Related]
39. Protein C and fibrinolysis: a link between coagulation and fibrinolysis.
de Fouw NJ; Haverkate F; Bertina RM
Adv Exp Med Biol; 1990; 281():235-43. PubMed ID: 2102614
[TBL] [Abstract][Full Text] [Related]
40. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
